|
DENND5B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.337400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.583500E-02 |
| Normal-vs-Stage2 |
2.534400E-01 |
| Normal-vs-Stage3 |
5.938200E-01 |
| Normal-vs-Stage4 |
5.573200E-01 |
| Stage1-vs-Stage2 |
9.458000E-01 |
| Stage1-vs-Stage3 |
3.174000E-01 |
| Stage1-vs-Stage4 |
3.668400E-01 |
| Stage2-vs-Stage3 |
4.812400E-01 |
| Stage2-vs-Stage4 |
5.135400E-01 |
| Stage3-vs-Stage4 |
9.484600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.821700E-02 |
| Normal-vs-AfricanAmerican |
2.020600E-01 |
| Normal-vs-Asian |
2.326000E-01 |
| Caucasian-vs-AfricanAmerican |
2.483100E-03 |
| Caucasian-vs-Asian |
4.631000E-01 |
| AfricanAmerican-vs-Asian |
7.705700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.858200E-01 |
| Normal-vs-Female |
5.962500E-02 |
| Male-vs-Female |
2.870400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.015800E-01 |
| Normal-vs-Age(41-60Yrs) |
7.460100E-02 |
| Normal-vs-Age(61-80Yrs) |
2.273800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.147000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.419700E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.527610E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.202400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.187800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.633400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.217400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.940000E-02 |
| Normal-vs-Grade 2 |
3.961600E-02 |
| Normal-vs-Grade 3 |
2.892000E-01 |
| Normal-vs-Grade 4 |
7.601200E-01 |
| Grade 1-vs-Grade 2 |
5.460800E-01 |
| Grade 1-vs-Grade 3 |
2.540000E-01 |
| Grade 1-vs-Grade 4 |
1.203390E-01 |
| Grade 2-vs-Grade 3 |
2.330000E-01 |
| Grade 2-vs-Grade 4 |
5.514300E-02 |
| Grade 3-vs-Grade 4 |
2.227400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.950400E-04 |
| Normal-vs-ccB subtype |
5.646800E-01 |
| ccA subtype-vs-ccB subtype |
3.981300E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.301900E-02 |
| Normal-vs-N1 |
3.670600E-01 |
| N0-vs-N1 |
7.996400E-01 |
|
|
